Gelteq Limited (NASDAQ:GELS – Get Free Report) was the target of a significant decline in short interest in August. As of August 14th, there was short interest totaling 12,658 shares, a decline of 62.6% from the July 30th total of 33,877 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 36,025 shares, the days-to-cover ratio is presently 0.4 days.
Gelteq Stock Down 2.6%
Shares of NASDAQ GELS traded down $0.01 during trading on Friday, hitting $0.56. The company had a trading volume of 11,509 shares, compared to its average volume of 29,622. The stock has a fifty day simple moving average of $0.59 and a two-hundred day simple moving average of $0.65. Gelteq has a fifty-two week low of $0.39 and a fifty-two week high of $2.02.
Gelteq (NASDAQ:GELS – Get Free Report) last released its earnings results on Tuesday, June 30th. The company reported ($0.12) EPS for the quarter.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on GELS
Hedge Funds Weigh In On Gelteq
An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP purchased a new position in shares of Gelteq Limited (NASDAQ:GELS – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq as of its most recent filing with the Securities & Exchange Commission.
About Gelteq
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.
Recommended Stories
- Five stocks we like better than Gelteq
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
